Indian stocks: Visit www.stage2stocks.com →

LifeMD, Inc.

Stage 4 · Declining · week 8

As of Oct 22, 2026, LifeMD is in Stage 4, the downtrend phase, now in week 8 (since Sep 2, 2026). It closed at $2.17, 65.6% below its 52-week high and below its 200-day average, which is falling.

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. More about the company

$2.17
-0.45% today
$105M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is LFMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 23w
S4 18w
S1 17w
S2 14w
S4 26w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 23w → S3 7w → S2 11w → S3 6w → S4 18w → S1 17w → S4 1w → S2 4w → S3 2w → S2 14w → S3 6w → S4 26w → S1 12w → S2 5w → S3 6w → S4 7w current
Total tracked: 166 weeks across 16 stage runs.

LFMD among Health Information Services29th of 41 by relative strength

All 41 →
Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AMWLStage 2 · wk 2597+7.4%
2HNGEStage 2 · wk 2096+19.1%
3BTSGStage 3 · wk 894+9.1%
4NRCStage 3 · wk 493−0.1%
5SOPHStage 2 · wk 2491−12.7%
6HTFLStage 2 · wk 1087+17.0%
7HSTMStage 2 · wk 1777+20.3%
8OMCLStage 4 · wk 1070+12.5%
…29LFMDStage 4 · wk 817−28.9%
vs 52W High
-65.6%
$2.17 lo$6.30 hi
65.6% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 8
1w13w26w
Week 8, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-41.6%
200 DMA: $3.72 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.93x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-28.9%
3M
-41.5%
6M
-52.2%
YTD
-37.8%
1Y
-64.8%
Scan Membership
Breakout Watch
Latest: 2025-05-09
7 appearances in last 60 days. First seen: 2019-10-18.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 8 · Vol 0.93x
2026-10-21S4
Wk 7 · Vol 0.81x
2026-10-20S4
Wk 7 · Vol 0.91x
2026-10-19S4
Wk 7 · Vol 1.01x
2026-10-16S4
Wk 7 · Vol 1.05x
2026-10-15S4
Wk 7 · Vol 0.84x
2026-10-14S4
Wk 6 · Vol 0.76x
2026-10-13S4
Wk 6 · Vol 0.82x
2026-10-12S4
Wk 6 · Vol 0.72x
2026-10-09S4
Wk 6 · Vol 0.71x
2026-10-08S4
Wk 6 · Vol 1.07x
2026-10-07S4
Wk 5 · Vol 0.58x
Moving averages & range
50 DMA
$2.96
200 DMA
$3.72
52W High
$6.30
52W Low
$2.17
5D Low
$2.17
Resistance levels (recent highs)
20d High
$2.97
60d High
$3.90
120d High
$5.27
250d High
$6.30
Next resistance
+36.9%
to 20d High
ROE
-515.9%
Profit margin +0.1%
Dividend Yield
0.00%
P/B 13.0

LifeMD: quick answers

What stage is LifeMD in?

As of Oct 22, 2026, LifeMD (LFMD) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 2, 2026 and is in week 8. What the four stages mean

Is LifeMD in an uptrend?

No. LifeMD is in a Stage 4 downtrend. It trades 41.6% below its 200-day average, which is falling.

How far is LifeMD from its 52-week high?

LifeMD closed at $2.17 on Oct 22, 2026, 65.6% below its 52-week high of $6.30. Its 52-week low is $2.17.

How has LifeMD performed over the past year?

As of Oct 22, 2026, LifeMD is down 64.8% over the past year and down 37.8% so far in 2026.

Which sector and industry is LifeMD in?

LifeMD is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.